See every side of every news story

Published 10 days ago • loading... • Updated 9 days ago

Precision Medicine and Natalizumab

Summary by Multiple Sclerosis Research Blog

Can one control the crap-gap which occurs when natalizumab is given and the feeling of efficacy wanes before the next dose given every 4 weeks. Now we know that they can use an extended dosing inte…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

2 Articles

All

Left

Center

Right

centerforbiosimilars.com

Biosimilar Natalizumab-sztn Shows Comparable Efficacy and Safety to Tysabri in RRMS

Biosimilar natalizumab demonstrated comparable efficacy, safety, and immunogenicity to reference drug Tysabri in patients with relapsing-remitting multiple sclerosis (RRMS), supporting its potential as a cost-effective treatment option.

9 days ago

Read Full Article

Multiple Sclerosis Research Blog

Precision Medicine and Natalizumab

Can one control the crap-gap which occurs when natalizumab is given and the feeling of efficacy wanes before the next dose given every 4 weeks. Now we know that they can use an extended dosing inte…

10 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated8 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Multiple Sclerosis Research Blog broke the news in 10 days ago on Monday, March 24, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content. Stay informed with comprehensive global news coverage all in one place. Subscribe now to compare different perspectives, identify biases, and stay ahead of algorithms